For research and laboratory use only. Not for human or animal consumption. Not intended for diagnostic, therapeutic, or clinical use.
Retatrutide
Retatrutide from Primeva Labs is offered strictly for research use only. Each order includes batch-specific CoA documentation, quality verification, and secure online ordering. Not for human or animal consumption.
Primeva Labs supplies materials strictly for laboratory and research use. Create a complimentary research account to view current pricing, availability, and ordering.
By creating an account you confirm you are 21+, agree to the Terms & Research-Use Disclaimer, and acknowledge these products are sold strictly for research use — not for human or animal consumption.
What Is Retatrutide?
Retatrutide (LY3437943) is an investigational triple-receptor agonist acting at the GIP, GLP-1, and glucagon receptors, studied in metabolic and body-weight research.
- First triple agonist of the GIP, GLP-1, and glucagon receptors
- Studied extensively in obesity and metabolic-dysfunction models
- A major focus of current incretin-based metabolic research
- Supplied strictly as a research-grade reference material
Research Applications
Body-weight research
Studied in models of energy balance, appetite, and adiposity.
Glycemic-control research
Examined for effects on glucose handling via incretin pathways.
Hepatic-fat models
Investigated in research on liver-fat and metabolic-dysfunction-associated steatosis.
Energy-expenditure studies
Explored for glucagon-receptor contributions to energy expenditure.
Proposed Mechanisms
GLP-1 receptor agonism
Engages GLP-1 signaling associated with satiety and insulin secretion.
GIP receptor agonism
Adds GIP-receptor activity studied for complementary metabolic effects.
Glucagon receptor agonism
The third arm is studied for contributions to energy expenditure and lipid handling.
Combined incretin signaling
Tri-agonism is investigated for additive effects beyond single- or dual-agonists.
Mechanisms described above are drawn from preclinical (cell and animal) research and, where noted, early clinical literature. They are provided for educational context and should not be read as clinical or therapeutic claims.
